+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

From
From
From
From
From
From
Prescriber Opinions on Biosimilars in Immunology - Product Thumbnail Image

Prescriber Opinions on Biosimilars in Immunology

  • Report
  • March 2021
  • 45 Pages
  • Global
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
The State of the Biopharmaceutical Industry 2024 Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2024 Edition

  • Report
  • December 2023
  • 110 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more